NeuroPace, Inc.
NPCE
$8.42
-$0.14-1.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 88.57M | 84.31M | 79.91M | 76.45M | 71.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.57M | 84.31M | 79.91M | 76.45M | 71.82M |
| Cost of Revenue | 21.49M | 21.22M | 20.82M | 20.01M | 18.56M |
| Gross Profit | 67.08M | 63.08M | 59.09M | 56.44M | 53.26M |
| SG&A Expenses | 60.86M | 57.05M | 57.10M | 56.53M | 56.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 108.44M | 103.58M | 101.58M | 99.52M | 96.60M |
| Operating Income | -19.87M | -19.27M | -21.67M | -23.07M | -24.78M |
| Income Before Tax | -25.94M | -24.81M | -27.14M | -28.09M | -29.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.94 | -24.81 | -27.14 | -28.09 | -29.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.94M | -24.81M | -27.14M | -28.09M | -29.90M |
| EBIT | -19.87M | -19.27M | -21.67M | -23.07M | -24.78M |
| EBITDA | -19.66M | -19.06M | -21.46M | -22.87M | -24.60M |
| EPS Basic | -0.83 | -0.83 | -0.94 | -0.99 | -1.09 |
| Normalized Basic EPS | -0.53 | -0.52 | -0.59 | -0.61 | -0.67 |
| EPS Diluted | -0.83 | -0.83 | -0.94 | -0.99 | -1.09 |
| Normalized Diluted EPS | -0.53 | -0.52 | -0.59 | -0.61 | -0.67 |
| Average Basic Shares Outstanding | 123.70M | 119.69M | 116.50M | 113.38M | 109.96M |
| Average Diluted Shares Outstanding | 123.70M | 119.69M | 116.50M | 113.38M | 109.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |